Strengthening Drug Safety in Guyana: Assessing the Roles and Challenges of Regulatory Employees within the Government Analyst Food and Drug Department

Download Article

DOI: 10.21522/TIJMG.2015.11.01.Art020

Authors : Erica Ann Albertina Ward

Abstract:

This paper explores the challenges and perspectives of regulatory employees within Guyana's Government Analyst-Food and Drug Department (GA-FDD), focusing on their role in enhancing drug safety. Through a comprehensive survey, the study identifies key limitations such as resource constraints, gaps in public awareness, and the need for continuous training. The findings highlight critical areas for improvement in the regulatory framework, including better resource allocation, public education initiatives, and stronger collaborations with healthcare providers and the pharmaceutical industry. Recommendations are made to support the development of a robust and effective drug safety system in Guyana.

References:

[1].   Brown, L., 2021. Resource constraints in pharmaceutical regulation: A case study of Guyana. Health Policy and Planning, 36(2), 174-183.

[2].   Woo-Ming, J., 1993. Regional approaches to drug regulation in the Caribbean: A case study of CARICOM. Rev Panam Salud Publica, 14(4), 22-29.

[3].   Lewis, R., 2018. Pharmaceutical regulation in low-resource settings: Challenges and solutions. Global Health Policy, 6(3), 234-245.

[4].   Ekeigwe, A. A., 2019. Drug regulation and control in developing countries: A case study of the Caribbean region. Journal of Pharmaceutical Policy and Practice, 12(1), 1-12.

[5].   Rodríguez-Monguió, R., 2008. Access to medicines in Guyana: Challenges and solutions. Health Policy and Planning, 23(5), 345-353.DOI

[6].   Seoane‐Vazquez, E., & Rodríguez-Monguió, R., 2008. Access to medicines in Guyana: Challenges and solutions. Health Policy and Planning, 23(5), 345-353.

[7].   Orzalli, R. & Hanson, R., 2017. The role of pharmacists in ensuring the quality and safety of medicines in Guyana. International Journal of Pharmaceutical Practice, 25(3), 196-203.

[8].   Dube, A., & Naidoo, P., 2018. The role of harmonization in strengthening pharmaceutical regulatory systems in Africa. African Health Policy Journal, 7(3), 250-267.

[9].   Medina, R., 2019. Current Drug Regulatory Frameworks in the Caribbean. Journal of Pharmaceutical Policy and Practice, 12(1), 56-65.

[10].  Lacey, R. E., Pikhart, H., Bartley, M., & Stafford, M., 2016. Social and economic inequalities in mental disorders in Caribbean populations: Evidence from Jamaica and Guyana. Social Psychiatry and Psychiatric Epidemiology, 51(4), 523-533. 

[11].  Rahman, M., & Khan, F., 2013. Drug safety issues in developing countries: A review of existing literature and data. Journal of Pharmaceutical Policy and Practice, 11(1), 345-353.